David van Brunt Senior Research Fellow and Head, Division of Evidence and Analytics AbbVie Introduce yourself and AbbVie? AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s Mission is to use its expertise, dedicated people and a … Read more
EHDEN has a dedicated work package (WP) focusing on the outreach and the sustainability of the project as it is today and beyond the 5-year timeframe of the project. In this article, WP6 Leads, Johann Proeve and Carlos Diaz zoom in on the work done so far in these two important workstreams. To guide … Read more
15 June, 2020, Brussels, Belgium: From 16 April – 14 May, EHDEN announced a rolling COVID-19 Rapid Collaboration Call. Its goal is to help clinicians, scientists, governments and the public to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe and effective. Upon conclusion of … Read more
As covered in Part l of the series, the world is still very much fighting the SARS-CoV- 2 pandemic, and in many countries, is still striving to deal with a growing number of COVID-19 patients. Clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, how best to manage … Read more
Gözde Susuzlu Briggs Project Coordinator European Patients Forum Introduce yourself and your the European Patients Forum? I’m Gözde Susuzlu, Project Coordinator at the European Patients Forum (EPF), based in Brussels, Belgium. I contribute to EHDEN and other digital health and health data related projects, such as DigitalHealthEurope and the Data Saves Lives initiative. The diversity … Read more
19 May, 2020, Brussels, Belgium: Clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe and effective. To help provide these answers, EHDEN announced a rolling COVID-19 Rapid Collaboration Call, which ran from 16 April – 14 … Read more
The world is still very much fighting the SARS-CoV- 2 pandemic, and in many countries, is still striving to deal with a growing number of COVID-19 patients. Clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe … Read more
Brussels, Belgium, 23 April, 2020: The European Health Data & Evidence Network (EHDEN) today announced the launch of the EHDEN Academy in Europe as an online educational resource for anyone working in the domain of real-world data use, and real-world evidence generation, with the aim of becoming a primary resource. An IMI2 (Innovative Medicines Initiative) … Read more
We are excited to announce that the EHDEN Academy will launch publicly on Thursday, 23rd of April! The EHDEN Academy aims to be a resource for all those who generate and utilise healthcare data, work technically with it (e.g. ETL and mapping of data to the OMOP common data model), and are involved in methodological … Read more
The latest edition of ‘Open Access Government’ features Nigel Hughes, our EFPIA co-lead, who discusses EHDEN and how it fits in an environment of AI hype, socio-political unrest and healthcare demands. The journal can be reached via here (with EHDEN featured on page 19-21), or you can download the copy of the EHDEN article directly … Read more